COCRYSTAL PHARMA, INC. (COCP) Free cash flow 2016–2025
COCRYSTAL PHARMA, INC. (COCP) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$8.2MFY2025 · since FY2016: -$14.7M → -$8.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.2M | +50.3% |
| FY2024 | -$16.5M | -11.6% |
| FY2023 | -$14.8M | +31.3% |
| FY2022 | -$21.5M | -68.4% |
| FY2021 | -$12.8M | -26.8% |
| FY2020 | -$10.1M | -489.6% |
| FY2019 | -$1.7M | +79.5% |
| FY2018 | -$8.3M | -19.8% |
| FY2017 | -$6.9M | +52.8% |
| FY2016 | -$14.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice